glp-1 ra cardiovascular benefits The of Therapy: Beyond Weight Loss GLP-1 medications are known for

As the popularity of these medications grows, so does the need for better awareness and clearer communication of possible complications

423 Rezafungin (Rezzayo ) was approved by the FDA in March 2023 for the treatment of candidemia and invasive candidiasis in adults, the first therapeutic treatment approved for invasive candida infections in nearly a decade

BYDUREON versus Insulin Glargine, Both as Add-on to Metformin or Metformin + Sulfonylurea Therapy A 26-week open-label comparator-controlled trial was conducted to compare the safety and efficacy of BYDUREON to titrated insulin glargine in patients with type 2 diabetes whose glycemic control was inadequate with metformin or metformin plus sulfonylurea therapy (Trial 3 - NCT00641056)

Selected well-studied and highly enriched ER proteins are denoted with gene names

by examining 78 patients admitted to Wuhan Hospital in China, showed an increased CRP level in patients with COVID-19 [24]